198 unknown. 198 Phase 1, 84 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 198 | Unknown 198 |
| Phase 2 | 84 | Unknown 84 |
Follow Neoplasms, Nerve Tissue: new trials by email Literature Review of Neoplasms, Nerve Tissue trials Research Report on Neoplasms, Nerve Tissue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma TS-2021 - Glioblastoma Multiforme, Glioma, Malignant | Phase 1 | Unknown | Beijing Neurosurgical Institute | 30 | 2024-08-29 | 2024-10-31 |
| Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma. ZG005, Etoposide, Cisplatin - Neuroendocrine Carcinoma | Phase 1 / Phase 2 | Unknown | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 93 | 2024-05-30 | 2024-06-14 |
| Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With Melanoma PV-001-DC - Metastatic Melanoma | Phase 1 | Unknown | PrimeVax Immuno-Oncology Inc. | 10 | 2024-04-01 | 2023-07-06 |
| A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies ILB-2109, Toripalimab - Head and Neck Cancer, Cervical Cancer | Phase 1 / Phase 2 | Unknown | Innolake Biopharm | 200 | 2023-07-25 | 2024-05-21 |
| Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma 68Ga-MGS5 - Medullary Thyroid Carcinoma | Phase 1 | Unknown | First Affiliated Hospital of Fujian Medical University | 20 | 2023-06-21 | 2024-07-25 |
| A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors RC198 Injection - Melanoma, Urothelial Carcinoma | Phase 1 | Unknown | RemeGen Co., Ltd. | 48 | 2023-06-05 | 2024-08-16 |
| B7-H3 CAR-T for Recurrent or Refractory Glioblastoma Temozolomide, B7-H3 CAR-T - Recurrent Glioblastoma, Refractory Glioblastoma | Phase 1 / Phase 2 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 40 | 2023-06-01 | 2022-12-28 |
| Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid) Cetuximab-IRDye800 - Glioblastoma, High-grade Glioma | Phase 1 | Unknown | University Medical Center Groningen | 21 | 2023-05-05 | 2023-07-03 |
| A Study of TY-1091 in Patients With Advanced Solid Tumors TY-1091 - RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer | Phase 1 / Phase 2 | Unknown | TYK Medicines, Inc | 248 | 2023-04-24 | 2024-01-30 |
| Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac® photochemotherapy using 3-(1-Butyloxy)ethyl-3-deacetyl-bacteriopurpurin-18-n-butylimide methyl ester(Photobac®) - Glioblastoma Multiforme of Brain, Glioma, Sarcomatous | Phase 1 | Unknown | Photolitec LLC | 30 | 2023-04-11 | 2023-04-13 |
| Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3 - Neuroendocrine Tumors | Phase 1 / Phase 2 | Unknown | Peking Union Medical College Hospital | 80 | 2023-03-23 | 2025-04-02 |
| KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma KD6001, Toripalimab - Melanoma | Phase 1 / Phase 2 | Unknown | Shanghai Kanda Biotechnology Co., Ltd. | 84 | 2023-03-22 | 2023-04-27 |
| A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma C5252 - Solid Tumor, Glioblastoma | Phase 1 | Unknown | ImmVira Pharma Co. Ltd | 51 | 2023-03-15 | 2022-10-12 |
| Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab fractionated radiotherapy, cadonilimab - Recurrent Glioblastoma | Phase 1 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 11 | 2023-02-28 | 2023-02-21 |
| Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03) Neo-T, Toripalimab, Tislelizumab - Solid Tumor | Phase 1 | Unknown | BGI, China | 6 | 2023-01-10 | 2023-07-10 |
| LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas Laser interstitial thermal therapy, Temozolomide - Recurrent Glioblastoma | Phase 1 / Phase 2 | Unknown | Beijing Tiantan Hospital | 10 | 2022-12-01 | 2022-12-23 |
| Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors VG2025, Nivolumab Injection [Opdivo] - Solid Tumor | Phase 1 | Unknown | Virogin Biotech Canada Ltd | 12 | 2022-11-09 | 2024-08-09 |
| Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma Pembrolizumab and Temozolomide - Glioblastoma | Phase 1 | Unknown | University of Louisville | 30 | 2022-11-01 | 2023-01-26 |
| An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas Recombinant Human Adenovirus Type 5 Injection - Malignant Melanomas | Phase 1 | Unknown | Fujian Cancer Hospital | 10 | 2022-10-27 | 2023-07-10 |
| Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02) Neo-T, Cyclophosphamide, Fludarabine - Solid Tumor | Phase 1 | Unknown | BGI, China | 21 | 2022-09-28 | 2023-04-04 |
Showing 20 of 198. Sign in to see all of them.
Melanoma (93) · Glioblastoma (57) · Glioma (27) · Carcinoma, Non-Small-Cell Lung (18) · Brain Neoplasms (12) · Neoplasm Metastasis (12) · Ovarian Neoplasms (12) · Astrocytoma (11) · Central Nervous System Neoplasms (11) · Gliosarcoma (11) · Colorectal Neoplasms (10) · Neuroendocrine Tumors (10) · Carcinoma, Renal Cell (9) · Lung Neoplasms (9) · Neoplasms (9)
Neoplasms by Histologic Type (198) · Neoplasms, Germ Cell and Embryonal (194) · Neuroectodermal Tumors (194) · Neoplasms (189) · Neoplasms by Site (124) · Neoplasms, Glandular and Epithelial (112) · Neuroendocrine Tumors (104) · Nevi and Melanomas (96) · Skin Diseases (95) · Skin and Connective Tissue Diseases (95) · Skin Neoplasms (92) · Neoplasms, Neuroepithelial (84) · Astrocytoma (48) · Glioma (48)
Temozolomide (21) · Nivolumab (12) · pembrolizumab (10) · Radiotherapy (9) · Cyclophosphamide (8) · toripalimab (7) · Ipilimumab (6) · aldesleukin (6) · fludarabine (6) · Carboplatin (5) · Interleukin-2 (5) · Bevacizumab (4) · Biopsy (3) · Granulocyte-Macrophage Colony-Stimulating Factor (3) · sargramostim (3)
Peking University Cancer Hospital & Institute (6) · Biocad (4) · Peking Union Medical College Hospital (4) · Assistance Publique - Hôpitaux de Paris (3) · Beijing Tiantan Hospital (3) · Second Affiliated Hospital, Zhejiang University, School of Medicine (3) · Xiangya Hospital of Central South University (3) · BGI, China (2) · Barrett Cancer Center (2) · Beijing Sanbo Brain Hospital (2) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (2) · European Organisation for Research and Treatment of Cancer - EORTC (2) · Genzyme, a Sanofi Company (2) · Herbert Irving Comprehensive Cancer Center (2) · Leaf Vertical Inc. (2)
United States (66) · China (58) · France (13) · Germany (11) · United Kingdom (10) · Israel (9) · Australia (7) · Italy (7) · Russia (7) · Spain (7) · Netherlands (6) · Belgium (5) · Switzerland (4) · South Korea (3) · Austria (2)
Amy E. Bock (2) · Jeffrey Raizer, MD (2) · Kenneth G. Lucas, MD (2) · Ronald E. Warnick, MD (2) · Sean Grimm, MD (2) · Song Lin, M.D. (2) · Abolhossein Shahverdi, PhD (1) · Adam Mamelak, MD (1) · Alexander Starodub, MD (1) · Ali Aljubran, MD (1) · Amirali Hamidieh, MD,PhD (1) · Andrew P. Beelen, MD (1)
PMID 16882708, PMID 18391430, PMID 20150268, PMID 22291006, PMID 25795722, PMID 28678778, PMID 28678784, PMID 29245310, PMID 29683790, PMID 29943374, PMID 30231931, PMID 31145289, PMID 31399936, PMID 31832728, PMID 33234662, PMID 33558721, PMID 33735809, PMID 33947696, PMID 33986124, PMID 34025640, PMID 34235085, PMID 34889232, PMID 35021863, PMID 35193932, PMID 35468680, PMID 35768164, PMID 35906549, PMID 36113895, PMID 36319717, PMID 36464584, PMID 36648215, PMID 36845633, PMID 36934257, PMID 36989829, PMID 37075254, PMID 37104017, PMID 37224228, PMID 37739939, PMID 38049523, PMID 38878175, PMID 39214650, PMID 39489747, PMID 39572525, PMID 39904560, PMID 40762797, PMID 42062531, PMID 42226303
2009 (2), 2015 (1), P30CA022453 (1), R01NS044687 (1), R44CA247127 (1), ZIAEB000073 (1)